Chicago - The promise of biochemotherapy for stage IV malignant melanoma has not held up to scrutiny, and the value of this form of treatment seems nil, according to recent discouraging findings from major phase III clinical trials.
The Connection Between COVID Lung Lesions and Skin Lesions
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
FDA Panel Questions Isotretinoin iPLEDGE REMS
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Photoprotection Can Improve Acne Outcomes
What's Trending in Skin Care: March 2023
2 Clarke Drive Cranbury, NJ 08512